Abstract: A method for evaluating a risk of a subject getting a specific disease includes steps of: storing a reference database that contains original parameter sets; selecting target alleles from an SNP profile derived from genome sequencing data of a subject; selecting target parameter sets from among the original parameter sets; calculating, for each of the target parameter sets, a race factor based on a global risk allele frequency and a group-specific risk allele frequency included in the target parameter set; calculating a genetic factor based on statistics, global reference allele frequencies, the race factors for the target parameter sets, and numbers of chromosomes in homologous chromosome pairs included in the target parameter sets; calculating a citation factor based on numbers of citation times included in the target parameter sets; and calculating a risk score based on the genetic factor and the citation factor.

Abstract: The present invention pertains to anti viral compounds. The disclosure includes a method for preventing and/or treating a virus infection through the inhibition of a cysteine protease in a virus and/or a sodium taurocholate cotransporting polypeptide in a cell, particularly SARS-COV-2 and hepatitis B virus (HBV). Also provided includes the composition/pharmaceutical composition for preventing and/or treating a virus infection comprising any of the compounds, pharmaceutically acceptable salt thereof, or its mixture, and the use of the compounds.

Abstract: The present invention relates to a method of preventing or treating a fibrotic condition, comprising administering an effective amount of composition to a subject in need thereof; wherein the composition comprises triterpenes extracted from Antrodia camphorate or Anisomeles indica.

Abstract: The present invention relates to a method of preventing or treating a fibrotic condition, comprising administering an effective amount of composition to a subject in need thereof; wherein the composition comprises triterpenes extracted from Antrodia-camphorate or anisomeles indica.

Abstract: A method of treating or alleviating autoimmune-related diseases is provided. The method includes administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition includes an extract of Amomum tsao-ko as an effective ingredient and a pharmaceutically acceptable carrier or salt.

Abstract: The present invention relates to a method of preventing or treating a fibrotic condition, comprising administering an effective amount of composition to a subject in need thereof; wherein the composition comprises triterpenes extracted from Antrodia camphorate or Anisomeles indica.

Abstract: A method of treating or alleviating autoimmune-related diseases is provided. The method comprises administering a pharmaceutical composition to a subject in need thereof. Moreover, the pharmaceutical composition comprises an extract of Amomum tsao-ko as an effective ingredient and a pharmaceutically acceptable carrier or salt.

Abstract: A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, Z is O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, —(C?O)-alkyl, —(C?O)-aryl, —(C?O)-alkyl-aryl, —(C?O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of —OH, —NO2, —NH2, —NR3R4, carbonyl, alkoxyl, alkyl or —OCF3, wherein R3 and R4 independently are H, alkyl, O2CH3, —(C?O)—CH3 or (C?O)—NH2.

Abstract: A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, Z is O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, —(C?O)-alkyl, —(C?O)-aryl, —(C?O)-alkyl-aryl, —(C?O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of —OH, —NO2, —NH2, —NR3R4, carbonyl, alkoxyl, alkyl or —OCF3, wherein R3 and R4 independently are H, alkyl, —SO2CH3, —(C?O)—CH3 or —(C?O)—NH2.

Abstract: The present application discloses a display panel and a display apparatus. The display panel includes a first substrate, a second substrate disposed opposite to the first substrate, a display area for displaying a screen and a non-display area disposed around the display area; the first substrate includes a color filter layer, a filler and a drive circuit; the color filter layer is disposed in the display area of the display panel; the drive circuit is disposed in the non-display area of the display panel, and the filler is disposed on a surface of the drive circuit.

Abstract: This application discloses a display panel and a display apparatus. The display panel includes a first signal line and a second signal line; an overlapping region is formed at an intersection of the second signal line and the first signal line; and the first signal line includes at least two sub-connection lines and the connection line crosses the overlapping region.

Abstract: The present invention pertains to a composition for preparing a medicament for preventing and/or treating a virus infection, especially a hepatitis B virus infection and/or a herpes simplex virus, and uses thereof.

Abstract: The present application relates to a driving selection circuit for a display panel. The driving selection circuit comprises a first multiplexer circuit provided between a display area and a first data driving circuit, and a second multiplexer circuit provided between the display area and a second data driving circuit. Further provided are a display panel and a display apparatus.

Abstract: The present application discloses a display panel and a display apparatus. The display panel includes a first substrate, a second substrate disposed opposite to the first substrate, a display area for displaying a screen and a non-display area disposed around the display area; the first substrate includes a color filter layer, a filler and a drive circuit; the color filter layer is disposed in the display area of the display panel; the drive circuit is disposed in the non-display area of the display panel, and the filler is disposed on a surface of the drive circuit.

Abstract: The present invention pertains to anti-coronaviral compounds. The disclosure includes a method for preventing and/or treating a coronavirus infection through the inhibition of a cysteine protease in a virus, particularly SARS-COV-2. Also provided includes the composition/pharmaceutical composition for preventing and/or treating a coronavirus infection comprising any of the compounds, pharmaceutically acceptable salt thereof, or its mixture, and the use of the compounds.

Abstract: The present application discloses a display panel and a display device. A non-display region of the display panel includes fan-out regions, and the fan-out regions are regions constituted by all first metal lines connected to each sub-source drive circuit and regions constituted by all second metal lines connected to each sub-gate drive circuit; and barriers are disposed between the fan-out regions.

Abstract: This application discloses a display panel and a display apparatus. The display panel includes a first signal line and a second signal line; an overlapping region is formed at an intersection of the second signal line and he first signal line; and the first signal line includes at least two sub-connection lines and the connection line crosses the overlapping region.

Abstract: The present application discloses a display panel and a display device. The display panel includes a first substrate, a second substrate opposite to the first substrate, and a light shielding layer configured to shield a non-display region of the display panel, where the light shielding layer is located outside the first substrate or the second substrate.

Abstract: The present application relates to a driving selection circuit for a display panel. The driving selection circuit comprises a first multiplexer circuit provided between a display area and a first data driving circuit, and a second multiplexer circuit provided between the display area and a second data driving circuit. Further provided are a display panel and a display apparatus.

Abstract: The present invention pertains to a method for inhibiting, reducing or reversing atherosclerosis or a composition or pharmaceutical composition for preventing or treating an atherosclerotic disease containing a preparation of Antrodia camphorata, and/or one or more active compounds isolated form Antrodia camphorataa.